<!DOCTYPE html><html lang="en">
<head><meta charset="UTF-8"><meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Insights from: ORYL F1 makes first strong impression</title><meta name='description' content='** &quot;Discover the latest insights from ORYL F1&#x27;s launch, a novel automated laser-based platform for measuring solubility and aggregation of drug molecules in the'><style>
        body { font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif; line-height: 1.7; max-width: 850px; margin: 25px auto; padding: 25px; color: #333; background-color: #f9f9f9; }
        h1.page-title { color: #2c3e50; border-bottom: 2px solid #3498db; padding-bottom: 12px; text-align: center; margin-bottom: 35px; font-size: 2.4em; }
        .article-content h1 { font-size: 1.9em; color: #34495e; margin-top: 30px; border-bottom: 1px solid #ddd; padding-bottom: 10px;}
        .article-content h2 { font-size: 1.6em; color: #34495e; margin-top: 30px; border-left: 4px solid #3498db; padding-left: 12px;}
        .article-content h3 { font-size: 1.3em; color: #50667a; margin-top: 25px;}
        .article-content p { margin-bottom: 1.1em; font-size: 1.05rem; }
        .article-content ul, .article-content ol { margin-bottom: 1.1em; padding-left: 35px; }
        .article-content li { margin-bottom: 0.6em; }
        .article-content img { max-width: 100%; height: auto; border-radius: 10px; margin: 20px auto; display: block; box-shadow: 0 5px 15px rgba(0,0,0,0.12); }
        .article-content a { color: #1e88e5; text-decoration: none; font-weight: 500; }
        .article-content a:hover { text-decoration: underline; color: #1565c0; }
        .article-content blockquote { border-left: 5px solid #bdc3c7; margin: 1.8em 10px; padding: 0.8em 15px; color: #555; background-color: #ecf0f1; border-radius: 5px;}
        .article-content pre { background-color: #2d2d2d; color: #f0f0f0; padding: 18px; border-radius: 6px; overflow-x: auto; font-family: 'Courier New', Courier, monospace; font-size: 0.95em; line-height:1.5; }
        .article-content code:not(pre code) { font-family: 'Courier New', Courier, monospace; background-color: #e8e8e8; padding: 3px 6px; border-radius: 4px; font-size: 0.9em;}
        .article-content table { border-collapse: collapse; width: 100%; margin-bottom: 1.2em; box-shadow: 0 2px 4px rgba(0,0,0,0.05); }
        .article-content th, .article-content td { border: 1px solid #ccc; padding: 10px 12px; text-align: left; }
        .article-content th { background-color: #f0f2f5; font-weight: 600; }
        .video-preview-container iframe { width: 100%; min-height: 420px; border-radius: 10px; box-shadow: 0 4px 8px rgba(0,0,0,0.1); }
        .lyrics-details { margin: 25px 0; border: 1px solid #ddd; border-radius: 8px; padding:18px; background-color: #fff; box-shadow: 0 3px 7px rgba(0,0,0,0.06); }
        .lyrics-details summary { font-weight: bold; font-size: 1.1em; cursor: pointer; color: #444; margin-bottom: 12px; }
        .lyrics-details .lyrics-meta { font-size:0.9em; color:#666; margin-bottom:10px; line-height:1.5; }
        .lyrics-details pre { white-space: pre-wrap; word-wrap: break-word; max-height: 600px; overflow-y: auto; background-color: #f5f5f5; padding: 15px; margin-top:10px; border-radius:5px; font-size: 0.95em; line-height: 1.65; color: #222;}
        .article-meta { font-size: 0.9em; color: #555; margin-bottom: 20px; padding: 12px; background-color: #f0f8ff; border-left: 4px solid #64b5f6; border-radius: 5px; line-height:1.5; }
        .in-article-product-box { border: 1px solid #e0e0e0; padding: 18px; border-radius: 10px; margin: 25px 0; display: flex; align-items: flex-start; background-color: #fff; box-shadow: 0 4px 10px rgba(0,0,0,0.07); }
        .in-article-product-box img { max-width: 100px; max-height:120px; height: auto; object-fit: contain; margin-right: 20px; border-radius: 6px; }
        .in-article-product-box .product-details { flex-grow:1; }
        .in-article-product-box .product-details h4 { margin-top: 0; margin-bottom: 8px; color: #2c3e50; font-size: 1.15em; }
        .in-article-product-box .price { color: #c0392b; font-weight: bold; margin-bottom: 8px; font-size: 1.1em; }
        .in-article-product-box p { font-size: 0.9em; color: #666; margin-bottom: 12px; }
        .in-article-product-box .buy-btn { display: inline-block; background-color: #f1c40f; color: #2c3e50; padding: 10px 18px; border-radius: 6px; text-decoration: none; font-weight: bold; font-size:0.95em; transition: background-color 0.2s; }
        .in-article-product-box .buy-btn:hover { background-color: #e6b400; }
        </style>
</head><body><h1 class="page-title">Insights from: ORYL F1 makes first strong impression</h1><div class="article-meta webpage-meta">
                                   <p>Content analysis based on information from titled "ORYL F1 makes first strong impression": <a href="https://www.startupticker.ch/en/news/oryl-f1-makes-first-strong-impression" target="_blank">https://www.startupticker.ch/en/news/oryl-f1-makes-first-strong-impression</a></p>
                                </div><div class='article-content'><p><strong>Insights from: ORYL F1 makes first strong impression</strong></p>
<p>The launch of ORYL F1, a novel automated laser-based platform for measuring solubility and aggregation of drug molecules in the Life Science industry, marks a significant achievement for EPFL spin-off ORYL Photonics. This innovative instrument has already garnered interest from several large pharmaceutical companies in the Basel area, highlighting its potential to revolutionize the field.</p>
<p><strong>Understanding the Problem: Solubility and Aggregation in Drug Development</strong></p>
<p>Solubility and aggregation are critical factors in drug development, as they can significantly impact a molecule's efficacy and stability. Currently, measuring these properties requires manual labor-intensive processes, which can be time-consuming and costly. The lack of standardized methods for solubility and aggregation measurement has led to a significant gap in the market, making it challenging for researchers to make informed decisions.</p>
<p><strong>The ORYL F1: A Game-Changer in Solubility and Aggregation Measurement</strong></p>
<p>The ORYL F1 is designed to bridge this gap by providing a high-throughput, automated platform for measuring solubility and aggregation of drug molecules. This instrument utilizes second harmonic scattering, a laser-technology known for its unparalleled sensitivity in probing the structure of materials at molecular level.</p>
<p><strong>Key Features and Advantages</strong></p>
<p>The ORYL F1 offers several key features that set it apart from existing methods:</p>
<ul>
<li><strong>High-throughput capabilities</strong>: The instrument can measure 384 well-plates in just 15 minutes, significantly increasing throughput and unlocking solubility and aggregation measurement at scale.</li>
<li><strong>Automated format</strong>: The ORYL F1 is designed to be user-friendly, with an automated format adapted to 96 and 384 well-plates.</li>
<li><strong>Cost savings</strong>: The instrument achieves significant cost savings by simplifying the measurement process while preserving samples for orthogonal measurements and kinetics studies.</li>
</ul>
<p><strong>Market Recognition and Future Plans</strong></p>
<p>The ORYL F1 has already received positive market feedback, particularly for key applications that other technologies cannot measure. Several large pharmaceutical companies in the Basel area are using the service and have expressed interest in purchasing the instrument.</p>
<p>ORYL Photonics is currently finalizing a round of fundraising to support commercialization efforts, including expanding its team and developing sales in Switzerland and Europe. With its innovative technology and growing market recognition, ORYL Photonics is poised to make a significant impact in the Life Science industry.</p>
<p><strong>Target Audience</strong></p>
<p>The ORYL F1 is primarily aimed at researchers in the pharmaceutical, chemical, and life science industries who require accurate and efficient solubility and aggregation measurement. This includes:</p>
<ul>
<li>Pharmaceutical companies</li>
<li>Screening facilities</li>
<li>University laboratories</li>
<li>Researchers working on drug development projects</li>
</ul>
<p>By providing a high-throughput, automated platform for measuring solubility and aggregation, the ORYL F1 has the potential to revolutionize the field of drug development.</p>
<p><strong>Conclusion</strong></p>
<p>The launch of ORYL F1 marks a significant achievement for EPFL spin-off ORYL Photonics. With its innovative technology and growing market recognition, this instrument is poised to make a significant impact in the Life Science industry. As researchers continue to explore new ways to improve drug development, the ORYL F1 offers a promising solution for measuring solubility and aggregation.</p>
<p>**</p></div></body></html>